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Objective: A transient but severe systemic leukopenia regularly occurs after 
the antagonization f heparin by protamine in patients and in animals. The 
aim of the present study was to investigate the site and mechanisms ofwhite 
blood cell retention during this transient leukopenia by studying the 
leukocyte-endothelial cell interaction in skeletal muscle venules. Methods: 
Syrian golden hamsters were equipped with a dorsal skinfold chamber for 
intravital fluorescence microscopy and arterial and venous catheters for 
drug infusion, blood pressure measurement, and blood sampling. Micro- 
hemodynamic parameters and leukocyte-endothelial cellinteractions were 
observed in one single collecting venule per animal after intravenous 
infusion of saline solution (control, n = 10), of protamine/n = 9), and after 
infusion of heparin followed by either intravenous protamine in = 9) or 
intraarterial protamine (n = 9).  Results: All parameters remained un- 
changed in the control group. Whereas venular diameters remained 
unchanged, protamine transiently increased arterial blood pressure and 
venular erythrocyte velocity in all groups. Systemic leukocyte counts and 
the venular leukocyte discharge concentration decreased concurrently after 
protamine administration by about 60% to 70% at 2 minutes while the 
fraction of rolling leukocytes and the number of adherent lenkocytes 
remained unchanged. Two and one-half minutes later, systemic leukocyte 
counts and venular discharge concentrations ormalized while the fraction 
of leukocytes rolling slowly along or adhering firmly to the venuiar 
endothelial wall increased considerably and similarly in all groups receiv- 
ing protamine. Myeloperoxidase (an indicator of polymorphonuclear leu- 
kocytes) determination i  20 separate hamsters 2 minutes after protamine 
infusion revealed increased myeloperoxidase activity exclusively in the 
lungs. Conclusion: The response of leukocytes to protamine infusion with or 
without prior heparinization is biphasic: initial retention of leukocytes in 
the lungs is followed by enhanced leukocyte-endothelial celt interaction in 
the systemic irculation. (J Thorac Cardiovasc Surg 1997;113:784-91) 
E nhanced interactions between leukocytes and the endothelium are considered a crucial early step 
in the process of leukocyte emigration and the 
subsequent inflammatory and immune responses? 
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Leukocyte-endothelial ce l interaction is implicated 
in numerous pathogenetic mechanisms such as adult 
respiratory distress syndrome, transplant rejection, 
atherosclerosis, and reperfusion injury. The recep- 
tor proteins on the surface of endothelial and white 
blood cells 1 are thought o mediate at least part of 
these phenomena. Conformational changes, en- 
hanced expression of preformed proteins on cell 
surfaces, as well as de novo synthesis of receptor 
proteins seem to occur during the activation of 
different receptor types. 1-3 
Pharmacologic nterventions have also been asso- 
ciated with altered leukocyte-endothelial ce l inter- 
action. Tangelder and Arfors 4 found that polyanions 
and polycations diminished the interaction between 
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leukocytes and the endothelium of mesenteric 
venules. Among these substances, heparin and pro- 
tamine are used clinically for blood anticoagulation 
and for the subsequent reversal of the anticoagula- 
tive effects of heparin, respectively. In human be- 
ings, the antagonization of heparin by protamine, 
which is routinely performed in cardiac surgery after 
weaning from cardiopulmonary b pass, can result in 
pulmonary hypertension and systemic hypotension, 
as well as leukopenia, thrombopenia, ctivation of 
the complement Cascade, and release of vasoactive 
eicosanoids (thromboxane A2, prostacyclin). 5-7 In 
animal experiments, the hemodynamic effects could 
be attenuated by a thromboxane synthetase inhibi- 
tor 8 and a complement antagonist. 9 Pulmonary hy- 
pertension was completely blocked by cyclooxygen- 
ase inhibitors 1° and a thromboxane receptor 
antagonist, 1!whereas the acute leukopenia caused 
by protamine remained virtually unaffected by these 
interventions. Pretreatment with dimethylthiourea, 
a free radical scavenger, attenuated the thrombox- 
ane release and pulmonary vasoconstriction after 
protamine in sheep, 8 but not in pigs) 2 Also, data 
Collected from leukopenic pigs suggest hat throm- 
boxane release and hemodynamic effects after hep- 
arin/protamine administration are not mediated by 
circulating leukocytes. 13Thus numerous investiga- 
tors described a transient leukopenia fter prota- 
mine; its meaning for the humoral and hemody- 
namic responses to protamine, however, remains 
unclear. Although several intravascular ctivators of 
leukocytes induced white blood cell retention and 
tissue damage mainly in the lungs (reviewed by J. C. 
Hoggt4), the site and mechanism of leukocyte reten- 
tion during the protamine-induced leukopenia have 
not yet been determined. 
Because leukocyte adhesion contributes to reper- 
fusion damage after cardiac ischemia, 15' 16 we char- 
acterized the heparin/protamine-induced leukocyte 
activation by direct in vivo observation after injec- 
tion of heparin, protamine, and the interaction of 
heparin with protamine using the dorsal skinfold 
chamber in the Syrian golden hamster. Margination 
of leukocytes in other organs was investigated by 
myeloperoxidase (MPO) determination. 
Methods 
Animal model and preparation. For intravital fluores- 
cence microscopy, we used the dorsal skinfold preparation 
in Syrian golden hamsters. 17This model permits the 
microscopic quantification of leukocyte-endothelial cel
interaction, vessel diameters, and erythrocyte velocity in 
postcapillary venules of a thin-striated skin muscle within 
the chamber tissue. All animals received humane care in 
compliance with the "Principles of Laboratory Animal 
Care" formulated by the National Society for Medical 
Research and the '!Guide for the Care and Use of 
Laboratory Animals" prepared by the Institute of Labo- 
ratory Animal Resources and published by the National 
Institutes of Health (NIH Publication No. 86-23, revised 
1985). The experimental preparation used in this study 
has been described in detail. 17 In brief, 6- to 8-week-old 
Syrian golden hamsters were anesthetized (pentobarbital, 
60 mg/kg intraperitoneally) and two titanium frames were 
implanted so as to sandwich the extended ouble layer of 
the dorsal skin. In a circular area of 15 mm in diameter, 
one layer was completely removed; the remaining layer, 
consisting of epidermis, subcutaneous ti sue, and a thin 
striated muscle, was covered with a transparent glass 
coverslip incorporated into one of the frames. Fine poly- 
ethylene catheters were implanted into the jugular vein 
and the carotid artery, passed subcutaneously to the 
dorsal side of the neck, and sutured to the titanium 
frames. The animals tolerated the dorsal skinfold cham- 
bers well and showed no signs of discomfort. Namely, no 
effects on sleeping habits and weight gains were observed. 
Intravital video microscopy. Two to 3 days after the 
preparation, the animals were sedated with pentobarbital 
(15 mg/kg intravenously) and placed under a microscope 
(Orthoplan, Leitz, Wetzlar, Germany). The carotid artery 
catheter was connected to a pressure transducer (Gould 
Instruments, Oxnard, Calif.) for continuous monitoring of 
arterial pressure. A ×25 water immersion objective 
(Leitz) was used to select one postcapillary or collecting 
venule with 30 to 50 /xm in diameter. These vessels are 
considered to be the major site of leukocyte-endothelium 
interaction i  response to several stimuli. 2" 18 
Autologous erythrocytes were stained with fluorescein 
isothiocyanate (FITC) in vitro as described previously ~9 
and injected (0.1 ml, hematocrit value 30%) intravenously 
10 minutes before the experiments. For visualization of 
leukocytes, the in vivo fluorescent marker hodamine 6G 
(0.1 ml, 40 mg/ml; Merck, Darmstadt, Germany) was 
injected intravenously 5 minutes before the experiments 
and every 10 minutes thereafter. Epiillumination was 
achieved with a 75-W Xenon lamp attached to a 
Ploemopak illuminator with an N 2 and an L 3 filter block 
(Leitz). Because of the different excitation and emission 
spectra of rhodamine 6G (530 to 560 nm, >580 nm) and 
FITC (450 to 490 nm, >515 nm), this system allowed for 
the separate visualization of erythrocytes and leukocytes 
by switching from the N 2 to the L 3 filter block, respec- 
tively. The microscopic images (Camera Hamamatsu 
C2400, Hamamatsu City, Japan) were stored on videotape 
and evaluated off-line by frame-to-frame analysis. Vessel 
diameters, erythrocyte center line velocity (Very), leuko- 
cyte flux (FLUXIeu) , and leukocyte Velocities (V~e~) were 
determined. The venular leukocyte discharge concentra- 
tion (LEUwn) 18 was calculated by the formula: 
LEUven = FLUX~eu/FLUXvol (1//xl) 
where FLUX~o 1 (volume flux) was estimated by V~ry times 
vessel cross-sectional area and divided by 1.6. For a single 
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leukocyte the adhesion index (AQ) was calculated from its 
individual velocity (Vle~) and V~y: 
AQ - (Very - V leu) /Very  
The degree of interaction of a single leukocyte with the 
endothelium was estimated from its AQ: not interacting 
cells, AQ = 0.0 to 0.5; rolling leuk0cytes (primary leuko- 
cyte-endothelial cell interaction) AQ = 0.6 to 0.9; and 
adherent leukocytes (secondary leukocyte-endothelial 
cell interaction) AQ = 1.0. Rolling leukocytes are given as 
percentage of the total number of cells passing through 
the observed vessel within the observation period. Adher- 
ent leukocytes are given as number per square millimeter 
of endothelial surface area as calculated from Vessel 
diameter and length of the vessel segment studied (150 to 
250/xm). 
MPO activity in tissue. To study the organ distribution 
of neutrophils at the nadir of peripheral leukocyte counts, 
that is, the peak of margination, we determined MPO 
activity in the lungs, liver, spleen, bowel, skeletal muscle, 
and skin. Twenty separate hamsters were anesthetized 
(pentobarbital, 60 mg/kg intraperitoneally), equipped with 
a jugular venous catheter, imd heparinized (350 IU/kg). 
Four minutes later either pr0tamine (6 mg/kg, n = 10) or, 
in control animals (n = 10), an equal volume of saline 
solution was injected. After 2 minutes the thorax was 
opened and the hearts quickly excised to induce instant 
circulatory arrest. The aforementioned organs were re- 
moved, cleared of connective tissu e, and stored at -70 ° C. 
MPO was extracted as described by Schierwagen, Bylund- 
Fellenius, and Lundberg. 2° MPO activity was determined 
photometrically b  the hydrogen peroxide-dependent ox-
idation of 3,3',5,5'tetramethylbenzidin at 655 nm and 
25 ° C. A kinetic method of calculating activity was used, 
and 1 unit of MPO activity was define d to alter extinction 
by 1.0/min. 
Experimental protoco I. After injection of FITC-labeled 
erythrocytes and rhodamine 6G, the first of a total of nine 
video sequences was recorded (t = -7  minutes). Each 
sequence contained 10 seconds of erythrocyte, 60 seconds 
of leukocyte, and again 10 seconds of erythrocyte obser- 
vation via the respective filter blocks. At t = -4  minutes, 
heparin (350 IU/kg, porcine, Heparin-Natrium, Braun, 
Melsungen, Germany) was injected intravenously, and at 
t=  0 minutes, protamine (6 mg/kg, salmine, Protaminsul- 
fat Novo, Novo Industrie, Mainz, Germany) was injected 
intravenously. Video recordings were obtained after hep- 
arin injection (t = -3  minutes) and after protamine 
injection (t = 0.5, 2, 4.5, 7, 10, 13, and 23 minutes). 
Arterial blood samples (80/xl) were drawn at t = - 1, 2, 5, 
15, and 25 minutes, and the number of leukocytes was 
determined in a 0.01 txl aliquot in a counting chamber 
(Neubauer, Zeiss, Jena, Germany). 
Study groups. The animals were arbitrarily assigned to 
four different groups so that two or more experiments 
performed on a single day were designated to different 
groups. Also, experiments from all fou~r groups were 
present from the onset o the end of the total study period 
to avoid time-dependent i fluences on the results. So that 
the stability of the preparation could be evaluated, control 
animals (control group, n = 10) received equal volumes of 
saline solution instead of heparin and pmtamine. The 
effects of protamine alone were studied in a group in 
which saline solution was given at t = -4  minutes and 
protamine at t = 0 minutes (protamine group, n = 9). In 
the third group the clinically established procedure of 
antagonization of heparin by intravenous injection of 
protamine was used (HPv group, n = 9). To assess the 
possible influence of the site of leukocyte activation on 
their interaction with the endothelium, we injected prota- 
mine into the ascending thoracic aorta via the carotid 
artery catheter in the animals of the fourth group (HPa 
group, n = 9). 
Statistics, All data given are means -+ standard error of 
the mean. Effects of heparin or protamine injections 
within the groups were evaluated by the Friedman rank 
analysis of variance. When these test results indicated 
significant differences within a group, single measure- 
ments after heparin or protamine injection were com- 
pared against he preceding baseline data by the Wilcoxon 
matched pairs test. Differences among study groups were 
evaluated by the Kruskal-Wallis test, followed by the U 
test to detect the groups actually different from each 
other. Statistical significance was set at p < 0.05, 
Results 
Hemodynamics. Hemodynamic  parameters  re- 
mained unchanged in the control group throughout 
the experiments. Baseline values of mean arterial 
pressur e were 104 -c_ 7, 103 _ 9, 98 ~- 8. and 98 -- 7 
mm Hg in the control, protamine. HPv, and HPa 
groups, respectively, and transiently (<4 minutes) 
increased by 21 : 7. 18 = 7, and 26 ~ 8 mm Hg in 
the protamine, HPv, and HPa groups 2 minutes 
after protamine. Diameters of the venules studied 
(one per experiment) ranged from 40.3 : 1.5 (HPv 
group) to 45.3 +_ 2.6 (control g roup) / ,m and did not 
change throughout the experiments. Erythrocyte 
velocity increased from baseline values between 
734 : 71 (HPv group) and 938 ~- 101 /zrn/sec 
(control group) by 21% to 42% immediately after 
protamine but returned to baseline values within 2 
minutes and remained unchanged thereafter. He- 
modynamic parameters remained unchanged after 
heparin injection in all study groups. 
Leukocyte concentrations. The number  of leuko- 
cytes in arterial blood samples, as well as the venular 
leukocyte discharge concentration, remained un- 
changed after heparin but decreased considerably, 
by 60% to 71%. immediately after protamine, reach- 
ing the nadir after 2 minutes (Figs. 1 and 2). Both 
parameters  were restored to baseline values or 
exceeded baseline values within 10 to 15 minutes 
after protamine infusion. 
Fraction of rolling leukocytes. At baseline, 20% 
to 25% of nonadherent leukocytes were defined as 
rollers (adhesion index: 0.6 to 0.9: Fig. 3). Injection 
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Fig. 1. Systemic leukocyte counts from arterial blood 
were determined 1 minute before and 2, 5, 15, and 25 
minutes after protamine injection ($ $ ). Heparin was 
given 4 minutes before protamine ($). Study groups: 
Control animals (n = 10) received neither heparin nor 
protamine but equal volumes of saline solution; the 
protamine group (group P, n = 9)was given saline 
solution at -4 minutes and protamine at time zero. H-P,v 
animals (n = 9) received heparin and protamine, both 
intravenously; H-P,a hamsters (n = 9) were given an 
intravenous injection of heparin, followed by protamine 
administration i to the aorta. All data are mean _+ 
standard error of the mean; #p < 0.05, all experimental 
groups versus the control group. 
of heparin caused a slight but significant decrease of 
rolling leukocytes in both HPv and HPa animals. 
Within the first 2 minutes after protamine adminis- 
tration, that is, at a time when the number of 
leukocytes discharged to the venules under observa- 
tion was diminished, the fraction of rolling leuko- 
cytes remained at the low pre-protamine levels. 
Only at 4.5 minutes after protamine was there an 
increase in the percentage of rollers, to about 200% 
of baseline values. Primary, intermittent leukocyte- 
endothelial cell interaction, as expressed by the 
proportion of rolling cells, remained increased until 
13 minutes after protamine. No difference between 
the study groups that received protamine was ob- 
served. In the control group, primary leukocyte- 
endothelial cell interaction in the investigated 
venules remained unchanged throughout the exper- 
iments. 
Adherent leukocytes. At baseline, 44 + 33, 15 _+ 
12, 44 + 35, and 0 adherent leukocytes per square 
millimeter of venular endothelial surface area were 
encountered in the control, protamine, HPv, and 
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Fig. 2. The leukocyte discharge concentration, that is, an 
estimation ofthe concentration f leukocytes in the blood 
passing the venules under investigation (one per animal), 
is given in percent of baseline immediately before prota- 
mine. $, Injection of heparin; $ J,, injection of pr0ta- 
mine. Microvascular data were obtained in one venule of 
each hamster before heparin (-7), after heparin (-3), 
and 0.5, 2, 4.5, 7, 13, and 23 minutes after protamine. For 
at~breviations of study groups see Fig. 1. All data are 
mean _+ standard error of the mean; #p < 0.05, all 
experimental groups versus the control group. 
HPa groups, respectively. Heparin reduced the 
number of adherent leukocytes in HPv hamsters to 
zero. Immediately after protamine, the number of 
adherent leukocytes remained low, commenced to 
increase after 2 to 4.5 minutes, and reached a 
maximum of 164 _+ 113, 153 + 75, and 249 _+ 134 
cells/mm 2 in the protamine, HPv, and HPa groups, 
respectively, at 4.5 or 7.5 minutes after protamine. 
Between 10 and 13 minutes after protamine, the 
number of adherent leukocytes had returned to 
baseline values and did not Change thereafter(Fig. 
4 ) .  
MPO organ distribution. Substantial mounts of 
MPO in control animals were detected in lungs 
(1.84 _+ 0.28 U/gm), liver (0.62 + 0.07 U/gm), spleen 
(4.3i _+ 1.00 U/gm), and intestine (0.91 + 0.23 
U/gm), but not in skin or skeletal muscle. Two 
minutes after heparin reversal by protamine, a sig- 
nificant increase of MPO activity occurred exclu- 
sively in the lungs (Fig. 5). 
Discussion 
The present study shows that protamine in both 
heparinized and untreated hamsters enhances the 
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Fig. 3. The number of leukocytes rolling along the endo- 
thelium of the venules under investigation (one per ani- 
mal) is given in percent of all nonadherent !eukocytes. $, 
Heparin; $ $, protamine injection. For definition Of 
study groups see Fig. 1. All data are mean _+ standard 
error of the mean; *p < 0.05, H-P,v versus the control 
group; #p < 0.05, all experimental groups versus the 
control group. 
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Fig. 4. The number of teukocytes adhering to the endo- 
thelium of the venules under investigation (one per ani- 
mal) is given in cells per square millimeter of endothelial 
surface area. $, Heparin; $ +, protamine injection. For 
definition of study groups see Fig. 1. All data are mean -+ 
standard error of the mean; *p < 0.05, H-P,a versus the 
control group; #p < 0.05, all experimental groups versus 
the control group. 
leukocyte-endothelial cell interaction in collecting 
venules of striated skin muscle. A biphasic response 
to protamine bolus injections was detected: during 
the first 1 to 2 minutes the venular leukocyte dis- 
charge concentration decreased, with leukocytes 
marginating in the lungs, whereas the interaction of 
the circulating leukocytes with the endothelium of 
peripheral venules appeared unaltered; at 4.5 min- 
utes after protamine injections, the leukocyte dis- 
charge concentration commenced returning to base- 
line values, whereas rolling and firm adhesion of 
leukocytes in collecting venules increased. 
In vivo microscopic observation of the leukocyte- 
endothelial cell interaction requires urgical exteri- 
orization of the tissue. The models most commonly 
used are the hamster skinfold or cheek pouch 
preparation, hamster or rat cremaster muscle, rat or 
rabbit mesentery, and the surfaces of solid organs 
such as brain or heart. Whereas timuli like ischemia 
and reperfusion damage or chemotactic agents pro- 
voked similar reactions in all these models, only the 
permanent hamster skinfold chamber allows for 
microcirculatory studies in unanesthetized animals 
without acute surgical trauma of the tissue under 
investigation. 
In the hamster skinfold preparation i this and in 
previous studies, 21 baseline leukocyte-endothelial 
cell interaction (5% to 25% rolling leukocytes) was 
present also during control conditions. Rolling and 
sticking of leukocytes remained constant in control 
animals throughout the study, suggesting that our 
experimental setup and the repeated microscopy did 
not alter leukocyte-endothelial cell interaction. 
Baseline leukocvte rolling was also reported for an 
acute preparation of rabbit mesentery (12 to 188 
leukocytes per venule and minute). 4 Since in human 
beings, as well as in all animals studied previously, 
including pigs, 1° 11, 13 sheep,8 dogs,22 rabbits,23 and 
rats. 24 protamine with or without prior application 
of heparin had caused transient leukopenia, we 
performed pilot studies and detected a similar de- 
crease of the leukocyte count in hamsters 2 minutes 
after protamine injection. To eliminate the effect of 
decreased systemic blood leukocyte counts on the 
results, we expressed all data concerning numbers of 
rolling leukocytes as percent of total numbers of 
leukocytes passing the observed vessels. In addition. 
the venular discharge concentration of leukocvtes. 
that is. the number of leukocytes in the blood 
delivered to the venules under investigation, was 
estimated. The transient decrease of the leukocyte 
discharge concentration after protamine occurred in 
parallel with the decrease of the leukocyte count in 
arterial blood. 
The effects of protamine, heparin, and several 
negatively charged macromolecules on the leuko- 
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cyte behavior in the rabbit mesentery microcircula- 
tion have been studied previously. 4 Inhibition of the 
leukocyte-endothelial cell interaction by heparin 
could be confirmed for venules of striated muscle in 
the present study. However, we were unable to 
reproduce the findings of Tangelder and Arfors 4 in 
rabbits--that the polycation protamine had a similar 
inhibiting effect on the rolling of leukocytes as the 
negatively charged sulfated polysaccharides. In the 
present study, protamine clearly increased rolling 
and sticking of leukocytes. Species differences do 
most certainly not account for this discrepancy, 
because profound transient leukopenia fter prota- 
mine or heparin/protamine has been described in 
rabbits as well. a3 Another explanation seems more 
likely: Tangelder and Arfors 4 used the transillumi- 
nation technique allowing for the visualization of 
slowly moving (i.e., rolling and sticking) leukocytes 
only. Thus the absolute number of leukocytes inter- 
acting with the endothelium was determined but 
could not be related to the total number of cells 
entering the observed venule. This has no influence 
on the results unless evere changes of the leukocyte 
discharge concentration occur, as was the case in 
our study after protamine. The authors accounted 
for the potential shortcoming of their technique by 
monitoring systemic leukocyte counts and reported 
stable cell counts during the first 2 hours of their 
studies. However, the exact time course of blood 
sampling for leukocyte count is not clear from the 
study protocol, and it seems likely that the transient 
(2- to 3-minute) leukopenia fter protamine, which 
occurs also in the rabbit, 23 was not covered by their 
protocol. Thus the decrease of the rolling leukocytes 
after protamine in Tangelder and Arfors' study 4
might reflect he decrease of the leukocyte discharge 
concentration, which has not yet been shown to 
occur during the protamine reaction. 
In all three groups that received protamine, sys- 
temic leukocyte counts, leukocyte discharge concen- 
tration, and rolling of leukocytes were altered com- 
parably. Thus the increased activation of the 
leukocyte-endothelial ce l interaction after prota- 
mine in hamsters eems to occur independently of
complement activation or release of thromboxane 
A2, which has been found only in heparinized ani- 
mals.8, ~, 2s Also, pretreatment of animals with a 
thromboxane A2 receptor antagonist abolished the 
hemodynamic effects of protamine, but not the 
leukopenia. 11 In species usceptible to complement 
activation, thromboxane A2 release and pulmonary 
hypertension after heparin/protamine-induced leu- 
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Fig. 5. The tissue concentration fMPO was determined 
in different organs of 20 separate hamsters 2 minutes after 
injection of saline solution (control, n = 10) or of prota- 
mine (protamine, n = 10). All data are mean _+ standard 
error of the mean; #p < 0.05, protamine group versus 
control group. 
kopenia was consistently more pronounced in hep- 
arinized animals than in animals that received pro- 
tamine alone, 1~' 23, 24 but it could not be abolished by 
complement depletion. 26 Thus the transient leuko- 
penia and activation of leukocyte-endothelial ce l 
interaction by protamine seem to result from two 
distinct mechanisms: first, a direct effect of prota- 
mine on leukocytes and/or venular endothelial cells, 
which is enhanced by prior heparinization possibly 
through a second, indirect effect via mediators uch 
as complement or thromboxane Aa. The site of 
protamine injection had no influence on these pa- 
rameters, which challenges the hypothesis that the 
initial site of cell activation would determine the site 
of leukocyte ntrapment. 7 
We detected a biphasic response to protamine. 
First, within 30 seconds until 5 minutes after prota- 
mine, the leukocyte discharge concentration (i.e., 
the number of leukocytes per unit of volume flow in 
the observed venules) decreased by more than 75% 
whereas local rolling or adhesion of these leukocytes 
remained unaltered. At the nadir of this venous 
leukopenia (2 minutes after protamine) the MPO 
data indicate preferential margination of leukocytes 
in the lungs. Only in a second phase, about 4.5 to 13 
minutes after protamine, when the number of leu- 
kocytes delivered to the venules under investigation 
again reached control values, did the number of 
rolling or adhering leukocytes increase simulta- 
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neously. Obviously, the white blood cells transiently 
marginated in the lungs during the initial phase of 
the reaction. After release of the leukocytes from 
the pulmonary pool in the second phase, the leuko- 
cyte-endothelial cell interaction was increased in 
venules of skin-striated muscle and thus, possibly, 
throughout the body. The number of rolling leuko- 
cytes increased 2 to 5 minutes earlier than the 
number of sticking leukocytes. This observation is
compatible with the hypothesis that leukocyte roll- 
ing is the first step in an adhesion cascade and 
precedes ticking and eventually emigration of the 
leukocyte. 1 
The molecular mechanisms involved in the in- 
crease of leukocyte-endothelial ce l interaction by 
protamine cannot be identified from the present 
data. In publications before identification of adhe- 
sion molecules, surface charges on white blood cells 
and endothelial cells were thought o play a major 
role in leukocyte adhesiveness to endothelial cells or 
to artificial surfaces. 27-a9 The negative surface 
charges on leukocytes and endothelial cells would 
promote cell separation by electrostatic repulsion, 
thereby preventing both leukocyte-leukocyte and 
leukocyte-endothelial ce l adherence. 2sProtamine 
and other polycations reduce the negative surface 
charge and increase adhesion of leukocytes to en- 
dothelial cells. 27' 29 The hypothesis that protamine- 
induced leukocyte adhesiveness is charge mediated 
is compatible with the finding that leukocyte adhe- 
siveness i reduced by heparin and numerous further 
negatively charged polysaccharides, 4 but increased 
by protamine and by a variety of other cations. 27 
After heparin/protamine injection, the increased 
adhesiveness of leukocytes to venular endothelium 
might be due to the enhanced expression of specific 
adhesion molecules on leukocyte and endothelial 
cell surfaces, t-3 Considering the time that is required 
for activation or up-regulation of cell adhesion 
molecules, L-selectin and the /32-integrin CDllb/ 
CD18 on leukocytes and P-selectin and intercellular 
adhesion molecule-1 on endothelial cells might 
possibly be involved in the rapid onset of leukocyte 
adhesion to endothelium after heparin/protamine 
injection.l' 3L-selectin is constitutively expressed on 
leukocytes, whereas P-selectin is prestored in endo- 
thelial cell granules. 1 CDllb/CD18 appears to be 
activated within seconds by a variety of mediators 
including the complement fragments C3~ and Cs~, 3
which are increased uring the heparin/protamine 
reaction in human beings 5' 6 and sheep. 8In a recent 
study in pigs, CD18 expression on neutrophils in- 
creased by 23% after heparin/protamine injection, 
and the putative inhibitor of CD]8 up-regulation, 
NPC 15669, attenuated both the leukopenia nd the 
hemodynamic response. 3° However, not only de 
novo expression but also avidity of preexpressed 
adhesion molecules may increase in response to a 
wide variety of stimuli. 31 The observation that biva- 
lent cations modulate avidity changes of /32-inte- 
grins 31 suggests a possible role for the polycation 
protamine in this activation mechanism. 
Identification of adhesion molecules involved in 
the protamine reaction in our hamster model by the 
respective antibody studies was not possible, be- 
cause available antihuman or antirodent antibodies 
do not cross-react with the hamster eceptor mole- 
cules. 
In conclusion, we detected a biphasic pattern of 
leukocyte activation after protamine, which oc- 
curred independently of prior heparinization and 
the site (venous or arterial) of protamine adminis- 
tration: within the first minutes after protamine 
administration, leukocytes temporarily marginated 
in the lungs while blood leukocyte counts and 
microvascular discharge of leukocytes m the sys- 
temtc circulation dropped by up to 70%. Later on. 
leukocytes were released from the lungs, but inter- 
action with peripheral venular endothelial cells was 
considerably increased. Although the molecular 
mechanisms of this reaction remain to be deter- 
mined, in cardiac surgery the protamine-induced 
increased adhesiveness of leukocytes might contrib- 
ute to white blood cell retention and myocardial 
damage in the reperfnsed heart after weaning from 
cardiopulmonary b pass. 
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